Dr Agarwals Eye Hospital Ltd.
Snapshot View

View in App

Prices View details >>

1004.40 -32.95 ▼-3.2%

27 January 2023, 04:01:00 PM
Volume: 1,799

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.dragarwal.com
Market Cap 472.07 Cr.
Enterprise Value(EV) 481.29 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 64.07 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 15.68 Trailing Twelve Months Ending 2022-12
Industry PE 47.03 Trailing Twelve Months Ending 2022-12
Book Value / Share 212.09 Trailing Twelve Months Ending 2022-12
Price to Book Value 4.74 Calculated using Price: 1,004.40
Dividend Yield 0.30 Period Ending 2022-03
No. of Shares Subscribed 0.47 Cr. 4,700,000 Shares
FaceValue 10
Company Profile
Dr.Agarwal's Eye Hospital has been promoted by Dr.J.Agarwal and his family members in 1994. Though the entire family has been in the profession of providing total eye care solutions for almost five decades prior to this, through various private limited company and partnership firms, owned by the family members. The Hospital has always been at the forefront of every medical advancement in the field of Ophthalmic care in the world and has several firsts to its credit. The Hospital is engaged in conducting continuous training and research and development programs and has over a period, developed an excellent team of highly skilled Ophthalmic specialists and surgeons, to assist in its growth plans.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.18%
1 Week
-21.50%
1 Month
-17.45%
3 Month
-14.72%
6 Month
+57.89%
1 Year
+31.40%
2 Year
+194.11%
5 Year
+34.38%
10 Year
+1042.01%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 14.05 26.67 0.16 27.78 21.02 29.55 26.91 -2.60 36.29
Return on Capital Employed (%) 16.58 18.81 7.70 28.26 31.70 34.30 39.87 16.92 42.41
Return on Assets (%) 3.74 8.53 0.05 8.87 7.65 11.01 9.55 -0.86 9.63

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 19 24 23 29 35 46 56 55 78 95
Non Curr. Liab. 12 13 25 24 24 40 71 42 173 188
Curr. Liab. 35 31 36 27 37 35 39 70 82 57
Minority Int.
Equity & Liab. 67 67 84 81 96 120 166 167 333 340
Non Curr. Assets 44 44 61 61 73 91 136 123 283 301
Curr. Assets 23 23 24 20 23 30 30 44 50 38
Misc. Exp. not W/O
Total Assets 67 67 84 81 96 120 166 167 333 340

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 113 118 137 149 153 170 176 140 201 254
Other Income 3 0 0 2 2 2 3 2 1 1
Total Income 116 118 137 150 156 172 179 142 202 256
Total Expenditure -102 -103 -121 -126 -129 -140 -129 -110 -143 -184
PBIDT 14 15 15 24 27 32 50 32 60 72
Interest -4 -4 -5 -4 -3 -4 -9 -7 -7 -7
Depreciation -6 -6 -11 -9 -10 -11 -21 -19 -20 -24
Taxation -1 0 1 -4 -7 -6 -6 -7 -8 -10
Exceptional Items
PAT 2 6 0 7 7 12 14 -1 24 30
Adjusted EPS 5 12 0 16 14 25 29 -3 51 64

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 11 12 14 17 20 19 25 39 34 57
Cash Fr. Inv. -6 -11 -10 -17 -8 -11 -25 -17 -11 -46
Cash Fr. Finan. -3 -3 -5 0 -12 -8 2 -20 -8 -4
Net Change 2 -3 -1 0 0 0 2 2 15 7
Cash & Cash Eqvt 6 3 1 2 2 2 4 6 22 28

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 74.42 74.02 73.77 73.60 72.38 72.15 72.00 71.91 71.90
Public 25.58 25.98 26.23 26.40 27.62 27.85 28.00 28.09 28.10
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 99.27 99.81 99.57 99.81 99.14 98.44 59.76 59.84 99.80

Announcements View Details >>

Sat, 21 Jan 2023
Results- Financial Results For The Quarter And Nine Months Ended December 31 2022
Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we wish to inform you that in terms of Regulation 30 33 and other applicable provisions of Listing Regulations the Board of Directors of the Company at its meeting held on January 21 2023 commenced at 12:00 Noon and concluded at 12:45 PM have inter alia approved the Un-audited financial results of the Company for the quarter and nine months ended December 31 2022.1) Copies of the Un-audited Financial Results and Limited Review Report issued by the Statutory Auditors of the Company for the quarter and nine months ended December 31 2022 is enclosed.2) The Company has made arrangement for the release of the Un-audited Financial results for the quarter and nine months ended December 31 2022 in the newspaper as per the requirement of the Listing Regulations
Sat, 21 Jan 2023
Board Meeting Outcome for Unaudited Financial Results And Limited Review Report For The Quarter And Nine Months Ended December 31 2022- Outcome Of The Board Meeting
Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we wish to inform you that in terms of Regulation 30 33 and other applicable provisions of Listing Regulations the Board of Directors of the Company at its meeting held on January 21 2023 commenced at 12:00 Noon and concluded at 12:45 PM have inter alia approved the Un-audited financial results of the Company for the quarter and nine months ended December 31 2022.1) Copies of the Un-audited Financial Results and Limited Review Report issued by the Statutory Auditors of the Company for the quarter and nine months ended December 31 2022 is enclosed.2) The Company has made arrangement for release of the Un-audited Financial results for the quarter and nine months ended December 31 2022 in the newspaper as per the requirement of the Listing Regulations.
Wed, 18 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Disclosure under Regulation 39(3) of the SEBI (LODR) Regulations 2015 for the issue of duplicate share certificates is submitted.

Technical Scans View Details >>

Fri, 27 Jan 2023
Closing Below Previous Low Closing Below Previous Low
Close Below Last Week Low Close Below Last Week Low
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Dr Agarwals Eye Hospital Ltd.

What is Dr Agarwals Eye Hsp share price?
Can I buy Dr Agarwals Eye Hsp shares now?
What is the Dividend Yield of Dr Agarwals Eye Hsp?
What is the Market Cap of Dr Agarwals Eye Hsp?
What are the key metrics to analyse Dr Agarwals Eye Hsp?
What is the 52 Week High and Low of Dr Agarwals Eye Hsp?
What is the trend of Dr Agarwals Eye Hsp share price?